Safety and efficacy of regorafenib post-marketing surveillance (PMS) in Japanese patients with metastatic colorectal cancer (mCRC).
暂无分享,去创建一个
T. Nishida | K. Muro | K. Sugihara | T. Satoh | H. Takikawa | Toshiaki Watanabe | H. Uetake | T. Yoshino | K. Yamaguchi | Y. Komatsu | T. Sunaya | M. Chosa | Y. Hamada | Y. Yamamoto | Takeyuki Kato